Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.
Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.
复制标题
整合测序发现了一个ATF1基序富集的分子特征,可区分透明细胞癌和粘液样癌。
DOI:
10.1016/j.oraloncology.2021.105270
复制
发表时间:
2021-06
期刊:
影响因子:
4.8
通讯作者:
Brenner JC
中科院分区:
文献类型:
--
作者:
Heft Neal ME;Gensterblum-Miller E;Bhangale AD;Kulkarni A;Zhai J;Smith J;Brummel C;Foltin SK;Thomas D;Jiang H;McHugh JB;Brenner JC
Salivary gland tumors are comprised of a diverse group of malignancies with widely varying prognoses. These cancers can be difficult to differentiate, especially in cases with limited potential for immunohistochemistry (IHC)-based characterization. Here, we sought to define the molecular profile of a rare salivary gland cancer called hyalinizing clear cell carcinoma (HCCC), and identify a molecular gene signature capable of distinguishing between HCCC and the histopathologically similar disease, mucoepidermoid carcinoma (MEC). We performed the first integrated full characterization of five independent HCCC cases. We discovered insulin-like growth factor alterations and aberrant IGF2 and/or IGF1R expression in HCCC tumors, suggesting a potential dependence on this pathway. Further, we identified a 354 gene signature that differentiated HCCC from MEC, and was significantly enriched for genes with an ATF1 binding motif in their promoters, supporting a transcriptional pathogenic mechanism of the characteristic EWSR1-ATF1 fusion found in these tumors. Of the differentially expressed genes, IGF1R, SGK1 and SGK3 were found to be elevated in the HCCCs relative to MECs. Finally, analysis of immune checkpoints and subsequent IHC demonstrated that CXCR4 protein was elevated in several of the HCCC cases. Collectively, our data identify an ATF1-motif enriched gene signature that may have clinical utility for molecular differentiation of HCCCs from other salivary gland tumors and discover potential actionable alterations that may benefit the clinical care of recurrent HCCC patients.
登录
查看更多内容
影响因子:
--
作者:
Qu X;Wu Z;Dong W;Zhang T;Wang L;Pang Z;Ma W;Du J
通讯作者:
Du J
影响因子:
3.7
作者:
Antonescu, Cristina R.;Katabi, Nora;Weinreb, Ilan
通讯作者:
Weinreb, Ilan
影响因子:
20.4
作者:
Camidge, D. Ross;Dziadziuszko, Rafal;Shaw, Alice T.
通讯作者:
Shaw, Alice T.
影响因子:
0.9
作者:
Birkeland, Andrew C.;Burgin, Sarah J.;Brenner, J. Chad
通讯作者:
Brenner, J. Chad
影响因子:
2.1
作者:
Burgess, Bridget;Ananthanarayanan, Vijayalakshmi;Charous, Steven
通讯作者:
Charous, Steven